Päffikon (SZ) Switzerland 19th of April 2021: Saiba Animal Health reported today that the rights for its two lead assets, SAH001 (HypoCat) and SAH003 (CAD vaccine) have been transferred from Benchmark Animal Health to a leading global Animal Health Company. In 2014 and in 2015, Saiba Animal Heath (HypoPet AG) and Benchmark Holdings PLC entered …Read More
Pfäffikon (SZ) Switzerland 9th of December 2020 – Saiba Animal Health reported today that it has executed a contract with Boehringer Ingelheim. Saiba Animal Health AG announced Wednesday the commencement of an agreement with Boehringer Ingelheim, a global leader in animal health. The new partnership will further enable a core element of Saiba’s business strategy, …Read More
Saiba Animal Health led consortium receives top ranking and funding from Eurostars Program for the research and development of a vaccine for African Swine Fever.
Zürich Switzerland 2nd of June 2020 – Saiba Animal Health AG today announced the ASF-INNOVAC consortium in which it is the lead SME was ranked 1st among 378 funding applications and will thus receive funding for 3 years to research and develop a vaccine against the African Swine Fever; one of the most serious infectious …Read More
Zürich Switzerland 2nd of October 2019 – Saiba Animal Health AG reported today that it has executed a contract with a top-tier global animal health company. Saiba Animal Health AG announced Wednesday the signing of an agreement with a major animal health company. The execution of this agreement is another important step in the companies …Read More
Key preclinical data for Saiba Animal Health’s cat allergy vaccine (HypoCat™ / VC001) published in leading allergy journal.
Zürich Switzerland 17th of April 2019 – Saiba Animal Health AG today announced the publication of important preclinical data for their cat allergy vaccine, HypoCat™. The data were published online 17th of April 2019 in an article entitled “Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human …Read More
Saiba Animal Health AG today announced the publication of proof of principle data for a vaccine with the potential to translate into a novel therapy for osteoarthritic pain in companion animals
Zürich Switzerland 19th of March 2019 – Saiba Animal Health AG today announced the publication of proof of principle data for a vaccine with the potential to translate into a novel therapy for osteoarthritic pain in companion animals. The data were published online 12th of March 2019 in an article entitled “Active immunisation targeting nerve …Read More